Blocking CB1 receptors or activating CB2 receptors protected mouse hearts from clozapine-induced inflammation and fibrosis, revealing opposing cannabinoid receptor roles in drug-induced cardiotoxicity.
Psychiatrists prescribing clozapine, cardiologists, and pharmacologists studying cannabinoid-drug interactions.
Opposite CB1/CB2 effects
What the researchers found
Clozapine decreased endocannabinoid levels and caused myocardial inflammation and fibrosis in mice. CB1 receptor antagonists (rimonabant, AM281) reduced heart damage, while CB2 receptor agonists (AM1241, JWH-133) also protected the heart. Combined treatment with both provided even greater protection.
Why it matters
Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia, but cardiotoxicity limits its use. Understanding how the endocannabinoid system mediates this damage could lead to cardioprotective co-treatments.
The numbers in context
Clozapine decreased endocannabinoid levels in serum and cardiomyocytes. CB1 receptors decreased and relocated intracellularly; CB2 receptors increased and moved to cell surface. Combined CB1 antagonist + CB2 agonist provided additive cardioprotection.
How the study worked
Mice received clozapine alone or with selective CB1 antagonists or CB2 agonists. Heart tissue was examined for inflammation, fibrosis, and receptor expression. Cultured cardiomyocytes were used to confirm direct cellular effects.
What this study cannot tell us
Mouse study with clozapine doses that may not directly translate to human therapeutic levels. The study did not test whether cardioprotection interfered with clozapine's antipsychotic efficacy. No human data.
How to read the evidence
Preliminary: mouse study with in vitro confirmation but no human data.
When this study was published
Published in 2019.
The bigger picture
This finding has implications beyond clozapine. The opposing roles of CB1 and CB2 receptors in cardiac inflammation could be relevant to understanding how cannabis use affects heart health more broadly.
Questions still open
- Could CB2 agonists be co-prescribed with clozapine to prevent cardiotoxicity without affecting its psychiatric benefits? Does cannabis use by schizophrenia patients on clozapine affect cardiac risk?
Common questions
Why is clozapine cardiotoxicity a concern?
Could cannabinoids protect the heart during clozapine treatment?
Read the original research
Opposite effects of cannabinoid CB1 and CB2 receptors on antipsychotic clozapine-induced cardiotoxicity.
British journal of pharmacology, 176(7), 890-905
Citation
Li, Liliang; Dong, Xiaoru; Tu, Chunyan; Li, Xiaoqing; Peng, Zhao; Zhou, Yiling; Zhang, Dingang; Jiang, Jieqing; Burke, Allen; Zhao, Ziqin; Jin, Li; Jiang, Yan. (2019). Opposite effects of cannabinoid CB1 and CB2 receptors on antipsychotic clozapine-induced cardiotoxicity.. British journal of pharmacology, 176(7), 890-905. https://doi.org/10.1111/bph.14591
Explore the wider topic
- Cannabis and Your Cardiovascular System: Heart Risk, Stroke, and What the Research Shows
- Cannabis and Your Heart: What the Cardiovascular Research Shows
- Coughing Up Black Stuff After Quitting Weed: What It Means
- Lung Recovery After Quitting Weed: The Complete Timeline
- Weed and Your Lungs: Recovery Timeline After Quitting
- Quitting Weed as a Woman: Hormones, Cycles, and Recovery
- Cannabis, Weight, and Diet: What Quitting Does to Your Appetite
- Sex After Quitting Weed: What Changes and What Doesn't
- Cannabis and Driving: DUI Laws, Impairment Science, and What You Need to Know
- Weed and Acne: Can Quitting Cannabis Clear Your Skin?
- Weed and Fertility: What Couples Should Know
- Weed and Your Gut: How Cannabis Affects Digestion
- Weed and Your Heart: Cardiovascular Effects and Recovery
- Weed, Testosterone, and Male Health: What the Research Actually Shows
- THC and Blood Pressure Medication: Cardiovascular Interactions
- THC and Caffeine: The Most Common Drug Combo on Earth